Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28605
Conference/Presentation Title: The efficiency of a novel asymmetrical cellulose triacetate dialysis membrane compared to a standard high-flux dialysis membrane; a pilot study.
Authors: Foo S.E.;Polkinghorne K. ;Uhe M.;Kerr P.G. ;Sin H.K.;Kameshwar K.;Damasiewicz M.
Monash Health Department(s): Nephrology
Institution: (Kameshwar, Damasiewicz, Polkinghorne, Foo, Uhe, Sin, Kerr) Department of Nephrology, Monash Health (Damasiewicz, Polkinghorne, Kerr) Department of Medicine, Monash University (Sin) Department of Nephrology, Kwong Was Hospital
Presentation/Conference Date: 19-Jan-2021
Copyright year: 2020
Publisher: Blackwell Publishing
Publication information: Nephrology. Conference: 55th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, ANZSN 2020. Virtual. 25 (SUPPL 3) (pp 34), 2020. Date of Publication: December 2020.
Abstract: Aim: To compare properties of a novel asymmetrical cellulose triacetate (ATA) dialyser (Solacia 190-H, Nipro) to a commonly used high-flux polysulfone dialyser (FX-80, Fresenius) in patients undergoing long-hour (>7 hours) haemodialysis (HD). Background(s): The ATA membrane is highly porous and less prone to performance degradation, compared to a conventional high-flux membrane, potentially resulting in enhanced clearance of middle and large-middle molecules, along with protein bound solutes. Method(s): 10 long-hour home HD patients were included in this randomized cross-over trial. Patients were randomized to 4 weeks of either the 190-H or FX-80 dialyser with subsequent cross-over to the other. The removal of small (urea, phosphate and creatinine), middle and large-middle molecules (beta-2 microglobulin [B2M], indoxyl sulfate [IS], albumin) and markers of inflammation (interleukin-6 [IL-6], malondialdehyde-modified low density lipoprotein [MDA-LDL]), were evaluated during the mid-week dialysis session of the fourth week of each dialyser sequence. All results are expressed as mean differences in corresponding reduction ratios (RR) between the FX-80 and 190-H dialysers after 8 hours of dialysis. Result(s): There was no significant difference in reduction in clearance of small molecules, with a RR difference for urea -2.43 (p = 0.19), creatinine -1.82 (p = 0.28) and phosphate -2.61 (p = 0.55). Similarly, there was no difference in clearance of middle and large-middle molecules with a RR difference for B2M 2.63 (p = 0.22), IS 2.48 (p = 0.69) and albumin -0.15 (p = 0.96). There was also no difference in expression of inflammatory markers with RR for IL-6 18.8 (p = 0.44) and MDA-LDL -8.0 (p = 0.3). Conclusion(s): Our study did not demonstrate a difference in clearance of small, middle and large-middle molecules, nor the expression of markers of inflammation between the FX-80 and H-190 dialysers.
Conference Start Date: 2020-11-28
Conference End Date: 2020-12-02
DOI: http://monash.idm.oclc.org/login?url=
http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/nep.13798
ISSN: 1440-1797
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/28605
Type: Conference Abstract
Subjects: controlled study
dialysis membrane
female
gene expression
genetic marker
home dialysis
human
inflammation
male
*pilot study
protein expression
randomized controlled trial
solute
albumin
beta 2 microglobulin
*cellulose triacetate
adult
endogenous compound
indican
interleukin 6
low density lipoprotein
malonaldehyde
perfluorobutyltetrahydrofuran
phosphate
polysulfone
urea
*cellulose triacetate membrane
creatinine
clinical trial
conference abstract
*pilot study
protein expression
randomized controlled trial
solute
human
home dialysis
genetic marker
gene expression
female
dialysis membrane
controlled study
adult
male
conference abstract
clinical trial
*cellulose triacetate membrane
inflammation
Type of Clinical Study or Trial: Randomised controlled trial
Appears in Collections:Conferences

Show full item record

Page view(s)

78
checked on Aug 29, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.